Literature DB >> 8207648

Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners.

T R O'Brien1, M P Busch, E Donegan, J W Ward, L Wong, S M Samson, H A Perkins, R Altman, R L Stoneburner, S D Holmberg.   

Abstract

Using lookback procedures and other methods, we identified and then prospectively followed human immunodeficiency virus type 1 (HIV-1)-infected transfusion recipients and their sex partners to determine AIDS incidence and risks of heterosexual transmission of HIV-1. At enrollment, 7 of 32 (21.9%) female partners of male recipients were themselves infected with HIV-1, as compared with none of 14 male partners of female recipients (p = 0.08). No additional episodes of transmission were observed. The prevalence of advanced immunodeficiency at enrollment was similar in male and female recipients. Male recipients with advanced immunodeficiency (CD4+ lymphocyte count < or = 0.20 x 10(9)/L or a history of clinical AIDS) at enrollment were more likely to have infected their female partners (odds ratio = 7.9; p = 0.03) than men with neither condition. Similarly, AIDS-free survival, as estimated by the product-limit method, was lower among male transmitters than among male nontransmitters (p = 0.01). Transmission was not associated with frequency of unprotected vaginal intercourse. Our data suggest that HIV-1-infected men who develop immunodeficiency rapidly are more likely to infect their sex partners and that the greater efficiency of male-to-female HIV-1 transmission is not explained by a greater number of sexual contacts or more advanced immunodeficiency in index subjects.

Entities:  

Mesh:

Year:  1994        PMID: 8207648

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  13 in total

1.  Generalized additive models for current status data.

Authors:  S C Shiboski
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

Review 2.  Mechanisms of resistance to HIV infection.

Authors:  W A Paxton; R A Koup
Journal:  Springer Semin Immunopathol       Date:  1997

3.  HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection.

Authors:  Xiaojiang Gao; Thomas R O'Brien; Tania M Welzel; Darlene Marti; Ying Qi; James J Goedert; John Phair; Ruth Pfeiffer; Mary Carrington
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

4.  Gender differences in HIV risk behaviors in an adult emergency department in New York City.

Authors:  J Shuter; P L Alpert; M G DeShaw; B Greenberg; C J Chang; R S Klein
Journal:  J Urban Health       Date:  1999-06       Impact factor: 3.671

5.  Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex.

Authors:  Marisa N Madison; Philip H Jones; Chioma M Okeoma
Journal:  Virology       Date:  2015-04-13       Impact factor: 3.616

Review 6.  Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples.

Authors:  Rebecca F Baggaley; Richard G White; T Déirdre Hollingsworth; Marie-Claude Boily
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

Review 7.  Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis.

Authors:  Kimberly A Powers; Charles Poole; Audrey E Pettifor; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2008-08-04       Impact factor: 25.071

8.  HIV-1 disease progression is associated with bile-salt stimulated lipase (BSSL) gene polymorphism.

Authors:  Martijn J Stax; Neeltje A Kootstra; Angélique B van 't Wout; Michael W T Tanck; Margreet Bakker; Georgios Pollakis; William A Paxton
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

Review 9.  Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies.

Authors:  Marie-Claude Boily; Rebecca F Baggaley; Lei Wang; Benoit Masse; Richard G White; Richard J Hayes; Michel Alary
Journal:  Lancet Infect Dis       Date:  2009-02       Impact factor: 25.071

10.  SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.

Authors:  Paul J Feldblum; Adesina Adeiga; Rashidi Bakare; Silver Wevill; Anja Lendvay; Fatimah Obadaki; M Onikepe Olayemi; Lily Wang; Kavita Nanda; Wes Rountree
Journal:  PLoS One       Date:  2008-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.